A Threshold Model for T-Cell Activation in the Era of Checkpoint Blockade Immunotherapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A Threshold Model for T-Cell Activation in the Era of Checkpoint Blockade Immunotherapy

Published:2019-03-18 Issue: Volume:10 Page:
ISSN:1664-3224
Container-title:Frontiers in Immunology
language:
Short-container-title:Front. Immunol.

Author:

Guram Kripa,Kim Sangwoo S.,Wu Victoria,Sanders P. Dominick,Patel Sandip,Schoenberger Stephen P.,Cohen Ezra E. W.,Chen Si-Yi,Sharabi Andrew B.

Funder

University of California, San Diego

Publisher

Frontiers Media SA

Subject

Immunology,Immunology and Allergy

Reference204 articles.

1. Triad3A, an E3 ubiquitin-protein ligase regulating Toll-like receptors;Chuang;Nat Immunol,2004

2. Suppressor of cytokine signaling 1 negatively regulates Toll-like receptor signaling by mediating Mal degradation;Mansell;Nat Immunol,2006

3. An alternative and effective HIV vaccination approach based on inhibition of antigen presentation attenuators in dendritic cells;Song;PLoS Med,2006

4. De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling;Wertz;Nature,2004

5. The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses;Boone;Nat Immunol,2004

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cancer and Autoimmune Diseases as Two Sides of Chronic Inflammation and the Method of Therapy;Current Cancer Drug Targets;2024-11

2. Immunotherapeutic implications of negative regulation by protein tyrosine phosphatases in T cells: the emerging cases of PTP1B and TCPTP;Frontiers in Medicine;2024-04-19

3. When inflammatory stressors dramatically change, disease phenotypes may transform between autoimmune hematopoietic failure and myeloid neoplasms;Frontiers in Immunology;2024-02-15

4. YB-1-based oncolytic virotherapy in combination with CD47 blockade enhances phagocytosis of pediatric sarcoma cells;Frontiers in Oncology;2024-01-31

5. TCR-transgenic T cells and YB-1-based oncolytic virotherapy improve survival in a preclinical Ewing sarcoma xenograft mouse model;Frontiers in Immunology;2024-01-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3